Press release
Lupus Nephritis Market Expected to Reach US$ 5,296.0 Million by 2033 | IMARC Group
What is the total addressable market for lupus nephritis?
According to IMARC Group, in 2022, the total value of the seven major markets (7MM) for lupus nephritis amounted to US$ 2,063.9 Million. Looking forward, these markets are anticipated to reach US$ 5,296.0 Million by 2033, at a growth rate (CAGR) of 8.8% from 2023-2033.
What is Lupus nephritis?
Lupus nephritis is a condition that arises from systemic lupus erythematosus (SLE), an autoimmune disorder affecting various parts of the body, including the kidneys. This condition originates when the immune system mistakenly attacks the kidneys, resulting in inflammation and tissue damage. The common symptoms of lupus nephritis include fever, edema, joint and muscle pain, malar rash, foamy urine, fatigue, weight gain, and shortness of breath. If the ailment is not treated on time, it may lead to kidney failure as well. The diagnosis of lupus nephritis involves blood and urine tests to detect abnormalities in kidney function. The healthcare provider may also perform diagnostic procedures, including X-rays, kidney ultrasounds, and a kidney biopsy, to visualize the stage and extent of the disease.
Request a Free Sample Report: https://www.imarcgroup.com/lupus-nephritis-market/requestsample
The increasing incidences of autoimmune diseases, which lead to inflammation and scarring of the kidney tissues, are primarily driving the lupus nephritis market. In addition to this, the rising cases of numerous associated risk factors, such as genetic predisposition, certain infections, exposure to toxins, etc., are also augmenting the market growth. Moreover, the growing utilization of immunosuppressive drugs, including mycophenolate mofetil and azathioprine, to control the underlying symptoms of the disease is creating a positive outlook for the market.
Besides this, the inflating application of monoclonal antibodies that help reduce inflammation is also acting as another significant growth-inducing factor. Furthermore, numerous government authorities are taking initiatives to improve access to care for individuals with lupus nephritis, including increasing funding for healthcare facilities and reimbursement rates for providers. This, in turn, is projected to bolster the lupus nephritis market in the coming years.
Report Period:
Base Year: 2022
Historical Period: 2017-2022
Market Forecast: 2023-2033
Countries Included:
United States
Germany
France
United Kingdom
Italy
Spain
Japan
Analysis Covered Across Each Country
Historical, current, and future epidemiology scenario
Historical, current, and future performance of the lupus nephritis market
Historical, current, and future performance of various therapeutic categories in the market
Sales of various drugs across the lupus nephritis market
Reimbursement scenario in the market
In-market and pipeline drugs
In-Market Drugs
Drug Overview
Mechanism of Action
Regulatory Status
Clinical Trial Results
Drug Uptake and Market Performance
Late-Stage Pipeline Drugs
Drug Overview
Mechanism of Action
Regulatory Status
Clinical Trial Results
Regulatory Status
Ask an Analyst for Report Customization with TOC & List of figures: https://www.imarcgroup.com/request?type=report&id=7229&flag=C
Key Questions Answered in this Report:
How has the lupus nephritis market performed so far and how will it perform in the coming years?
What are the markets shares of various therapeutic segments in 2022 and how are they expected to perform till 2033?
What was the country-wise size of the lupus nephritis market across the seven major markets in 2022 and what will it look like in 2033?
What is the growth rate of the lupus nephritis market across the seven major markets and what will be the expected growth over the next ten years?
What are the key unmet needs in the market?
Browse the Latest Research Report:
Vascular Dementia Market Report : https://www.imarcgroup.com/vascular-dementia-market
Ophthalmoplegia Market Report: https://www.imarcgroup.com/ophthalmoplegia-market
Spinal Cord Injury Market Report: https://www.imarcgroup.com/spinal-cord-injury-market
Urinary Incontinence Drugs Market Report: https://www.imarcgroup.com/urinary-incontinence-drugs-market
How This Report Can Help You:
The report on lupus nephritis market presents a comprehensive overview and analysis of the epidemiology and market for this condition in the seven major markets (7MM): the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan.
With insights into both current and emerging therapies in the 7MM, this report offers valuable information for businesses seeking to understand trends and opportunities within the lupus nephritis market.
The lupus nephritis market report covers historical and forecasted market data, including epidemiology scenario, providing a reliable and informative resource for developing effective business strategies in 7MM.
Our report on the lupus nephritis market can help businesses stay abreast of the trends and drivers, gain a competitive edge and drive success.
Contact US
IMARC Group
134 N 4th St.
Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
About Us: -
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Lupus Nephritis Market Expected to Reach US$ 5,296.0 Million by 2033 | IMARC Group here
News-ID: 3116057 • Views: …
More Releases from IMARC Group
Australia Truck Market Projected to Reach USD 280.91 Million by 2033
Market Overview
The Australia truck market size was valued at USD 150.00 Million in 2024 and is projected to reach USD 280.91 Million by 2033. This growth is fueled by increasing demand in freight and logistics, sustainability initiatives, government infrastructure investments, and technological advancements. Fleet operators are progressively adopting cleaner and more efficient trucks to meet regulations and environmental expectations. Key trends include electrification, autonomous vehicle technology, and advanced safety systems.…
Australia Patient Handling Equipment Market Projected to Reach USD 451.29 Millio …
Market Overview
The Australia patient handling equipment market was valued at USD 263.87 Million in 2025 and is expected to reach USD 451.29 Million by 2034, growing at a compound annual growth rate of 6.14% during the forecast period of 2026-2034. Expansion is driven by an aging population needing specialized mobility and care, government funding for aged care modernization, and increased focus on workplace safety to reduce caregiver injuries. Technological advancements…
Australia Fermented Superfoods Market Projected to Reach USD 1,515.2 Million by …
Market Overview
The Australia fermented superfoods market attained a size of USD 715.2 Million in 2024 and is forecasted to grow to USD 1,515.2 Million by 2033. The market is expected to achieve this expansion over the forecast period from 2025 to 2033 at a compound annual growth rate of 8.7%. Growth is driven by the rising consumer awareness of gut health and demand for organic, locally sourced ingredients alongside continuous…
Mexico Mixed Xylene Market Size, Growth, Latest Trends and Forecast 2026-2034
IMARC Group has recently released a new research study titled "Mexico Mixed Xylene Market Size, Share, Trends and Forecast by Grade, End Use, and Region, 2026-2034" which offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends, and competitive landscape to understand the current and future market scenarios.
Market Overview
The Mexico mixed xylene market size was valued at USD 924.83 Million in 2025 and is projected to reach USD…
More Releases for Lupus
Cutaneous Lupus Erythematosus (CLE) Market
Introduction
Cutaneous Lupus Erythematosus (CLE) is a chronic autoimmune skin disorder, often associated with systemic lupus erythematosus (SLE), that presents as inflammation, rashes, and photosensitivity. While CLE is rarely fatal, it significantly affects patients' physical and emotional well-being, often leading to scarring, disfigurement, and social stigma.
Over the past decade, the market for CLE therapies has gained global importance as research into autoimmunity has accelerated and biologic therapies have transformed dermatology. Rising…
Prominent Cutaneous Lupus Erythematosus Market Trend for 2025: Advancements In C …
What combination of drivers is leading to accelerated growth in the cutaneous lupus erythematosus market?
The rising prevalence of skin infections is expected to drive the growth of the cutaneous lupus erythematosus (CLE) market. Skin infections are caused by microorganisms that invade the skin, triggering immune responses that can worsen symptoms in individuals with CLE. For example, the UK saw a 33.7% increase in MRSA cases caused by skin and soft…
Cutaneous Lupus Erythematosus (CLE) Market
Market Overview:
The Global Cutaneous Lupus Erythematosus (CLE) Market is forecasted to achieve a High CAGR during the period 2023-2030. CLE encompasses a spectrum of dermatological symptoms that may precede or accompany systemic lupus erythematosus (SLE), an autoimmune condition impacting multiple organs. Timely diagnosis and treatment of CLE can prevent the onset of severe systemic symptoms.
Market Dynamics:
Drivers:
Rise in Clinical Studies: Technological advancements leading to faster and accurate diagnosis have spurred additional…
Lupus Nephritis Treatment Market 2030
Global Lupus Nephritis Treatment market is expected to be worth roughly USD 8,048 million by 2030, growing at a CAGR of 7.3% during the forthcoming period of 2022-2030, according to Ameco Research
Lupus nephritis is one of the most rapidly spreading diseases over the globe. The increasing frequency of lupus nephritis and consumer awareness has fuelled the worldwide lupus nephritis treatment market. Another crucial factor driving the pace of growth of…
Lupus Erythematosus Market -API Insights, 2017
Summary
Orbis Research Present “Lupus Erythematosus-API Insights, 2017”
Description
The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market.
India and China produce a large percentage…
Global Systemic Lupus Erythematosus and Lupus Nephritis Market to Display 10.6% …
"The Report PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2025 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
MarketResearchReports.biz has announced the addition of a new report, titled “PharmaPoint: Systemic Lupus Erythematosus And Lupus Nephritis - Global Drug Forecast And Market Analysis To 2025,” to its expanding repository of research reports. The market…
